What You Need to Know About Palladia (toceranib phosphate)

06/22/2009
Pfizer recently received FDA approval for a novel drug, Palladia that is indicated for the treatment of mast cell tumors in dogs.

Pfizer recently received FDA approval for a novel drug, Palladia that is indicated for the
treatment of mast cell tumors in dogs. The release of Palladia has generated a significant
amount of excitement as not only is it a novel drug for the treatment of mast cell tumors
but it represents a new era in veterinary oncology. Palladia will be available only through
veterinary oncologists and selected specialists until at least December of 2009. During
this time Pfizer will continue to gather data in regards to the safety and efficacy of
Palladia. Therefore in order for a patient to receive treatment with Palladia, they must be
referred to a veterinary oncologist or participating specialist.



Download Document 45.8 KB